Single-Pass Primary Analysis
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 63/072,649, filed Aug 31, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,200,446 | Single-Pass Primary Analysis In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 11,397,870 | Single-Pass Primary Analysis In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 11,915,444 | Single-Pass Primary Analysis In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 12,505,571 | Primary Analysis in Next Generation Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 12,469,162 | Primary Analysis in Next Generation Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 12,359,193 | Single-Stranded Splint Strands and Methods of Use In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 12,371,743 | Double-Stranded Splint Adaptors and Methods of Use In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| Application 18/587,555 | Single-Pass Primary Analysis Abandoned Abandoned Oct 21, 2024 | Element Biosciences, Inc. | Abandoned | Abandoned Oct 21, 2024 | ||
| Application 18/907,186 | Single-Pass Primary Analysis Abandoned Abandoned May 16, 2025 | Element Biosciences, Inc. | Abandoned | Abandoned May 16, 2025 | ||
| Application 19/209,343 | Single-Pass Primary Analysis Pending Not granted | Element Biosciences, Inc. | Pending | Not granted | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
7 of these are in force and held by Element Biosciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.